We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Drug Reviews Not Transparent Enough, Activists Say
FDA Drug Reviews Not Transparent Enough, Activists Say
October 13, 2006
The FDA does not do a good enough job in making drug development information available to the public, and proposals for clinical-trial registries do not go far enough to address this problem, the activist group Public Citizen said in a study published in the Duke Law Journal.